N-Phenacylthiazolium bromide (PTB)[1] is a cross-link breaker that in one study has been shown to prevent vascular
advanced glycation end-product accumulation in diabetic rats.[2]
References
^Chang, Po-Chun; Tsai, Sheng-Chueh; Chong, Li Yen; Kao, Man-Jung (July 22, 2014). "N-Phenacylthiazolium bromide inhibits the advanced glycation end product (AGE)-AGE receptor axis to modulate experimental periodontitis in rats". Journal of Periodontology. 85 (7): e268–276.
doi:
10.1902/jop.2014.130554.
PMID24988129.